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The Akt signaling pathway controls several
cellular functions in the cardiovascular system;
however, its role in atherogenesis is unknown.
Here, we show that the genetic ablation of
Akt1 on an apolipoprotein E knockout back-
ground (ApoE/Akt1/) increases aortic le-
sion expansion and promotes coronary athero-
sclerosis. Mechanistically, lesion formation is
due to the enhanced expression of proinflam-
matory genes and endothelial cell and macro-
phage apoptosis. Bone marrow transfer ex-
periments showing that macrophages from
ApoE/Akt1/ donors were not sufficient to
worsen atherogenesis when transferred to
ApoE/ recipients suggest that lesion expan-
sion in the ApoE/Akt1/ strain might be of
vascular origin. In the vessel wall, the loss of
Akt1 increases inflammatory mediators and re-
duces eNOS phosphorylation, suggesting that
Akt1 exerts vascular protection against athero-
genesis. The presence of coronary lesions in
ApoE/Akt1/ mice provides a new model
for studying the mechanisms of acute coronary
syndrome in humans.
INTRODUCTION
Atherosclerosis is a chronic inflammatory process in-
volving complex interactions of modified lipoproteins,
monocyte-derived macrophages or foam cells, T lym-
phocytes, endothelial cells, smooth muscle cells, and
fibroblasts (Glass and Witztum, 2001; Libby, 2002). The
PI3K-Akt signaling pathway is involved in the regulation
of cell metabolism, survival, migration, and gene expres-
sion in various cell types (Cantley, 2002; Whiteman et al.,
2002). In the vascular wall, Akt has been shown to play an
important role in the proliferation and migration of endo-446 Cell Metabolism 6, 446–457, December 2007 ª2007 Elsethelial cells, regulation of vascular permeability, and an-
giogenesis (Ackah et al., 2005; Chen et al., 2005; Phung
et al., 2006). Recent studies of Akt knockout mice have
shown that despite significant sequence homology, the
three Akt isoforms have some nonredundant functions.
Although Akt1-deficient mice exhibit overall growth
impairment (Chen et al., 2001; Cho et al., 2001b), Akt2
knockout mice have impaired glucose tolerance and in-
sulin resistance (Cho et al., 2001a), and Akt3 nulls display
a selective reduction in brain size (Easton et al., 2005;
Tschopp et al., 2005). We have recently shown that
Akt1 is an important Akt isoform expressed in endothelial
cells and that the loss of Akt1 results in reduced endothe-
lial nitric oxide synthase (eNOS) phosphorylation, nitric
oxide (NO) release, endothelial cell migration, and im-
paired vascular endothelial growth factor (VEGF)- and is-
chemia-induced angiogenesis (Ackah et al., 2005). How-
ever, in vitro studies suggest that Akt1 might play either
a proatherogenic or antiatherogenic role. For example,
eNOS-derived NO has physiological properties that can
be atheroprotective, including the inhibition of apopto-
sis, smooth muscle cell proliferation, platelet aggrega-
tion and adhesion, and leukocyte activation and adhe-
sion (Ignarro and Napoli, 2004; Kuhlencordt et al.,
2001). However, PI3K-Akt activation enhances macro-
phage survival in lesions, and the persistent activation
of Akt promotes cellular hypertrophy and hyperplasia,
thereby promoting atherogenesis (Dzau et al., 2002;
Shiojima et al., 2005). The integrative role of Akt1 in ath-
erogenesis in vivo is therefore not clear. Here, we show
that ApoE/Akt1/mice fed a high cholesterol diet ex-
hibit markedly enhanced aortic atherosclerosis com-
pared to their littermates. More importantly, the absence
of Akt1 leads to extensive coronary atherosclerosis,
a phenotype previously observed in mice lacking at least
two components of cholesterol metabolism (Braun et al.,
2002; Caligiuri et al., 1999) or in apoE-deficient mice
maintained on a Western-type diet for 10 months (Naka-
shima et al., 1994; Reddick et al., 1994). The increased
atherogenesis in mice lacking Akt1 is mechanistically
linked to endothelial cell dysfunction and enhanced apo-
ptosis in vascular cells.vier Inc.
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Coronary Atherosclerosis in Absence of Akt1Figure 1. Deletion of Akt1 Accelerates Atherosclerosis in ApoE/ Mice
(A–E) Oil red O staining of aortas frommicewith the indicated genotypes. Atheroma formationwas significantly increased inApoE/Akt1/mice (n =
7 mice) compared to ApoE/ littermates (n = 10).
(F) Representative examples of cross-sections from the aortic sinus stained with hematoxylin and eosin. The inset refers to lesions in the coronary
ostia of Akt1/ApoE/ mice. Quantification of atheroma area is shown. All of the data represent the mean ± SEM; n = 5 mice in each group.
(G) Representative histological analysis of coronary arteries stained with hematoxylin and eosin, trichrome, oil red O, CD68 (a macrophage marker),
and a-smooth muscle cell actin.
(H) Ex vivo angiograms of ApoE/ (top) and ApoE/Akt1/ (botton) hearts. Arrowheads indicate multiple severe stenoses in coronary arteries.RESULTS
Enhanced Atherosclerosis and Coronary
Occlusive Lesions in the Absence of Akt1
To study the functional role of Akt1 in atherogenesis, we
subjected double knockout ApoE/Akt1/ and corre-
sponding ApoE/ mice to a high cholesterol diet for 14
weeks and opened aortas longitudinally and stained
them with oil red O to visualize lipid-rich, atherosclerotic
plaques. As shown in Figures 1A and 1B, the absence of
Akt1 increased the number and size of aortic plaques. Le-
sion areas were greater particularly in the aortic arch
(Figure 1C) and thoracic aorta (Figure 1D) compared to
the abdominal region (Figure 1E). In another cohort of
mice, we quantified lesion areas in cross-sections of theCell Maortic sinus. As shown in Figure 1F, the loss of Akt1
increased the lesion area in the sinus compared to that ob-
served in ApoE/ mice. Moreover, we observed severe
atherosclerosis in the coronary ostia, epicardial common
coronary artery, and intramyocardial branches (Figure 1G,
see Figure S1 in the Supplemental Data available with this
article online for serial sectional analysis of coronary le-
sions) in all doubly mutant mice analyzed (n = 12). This
phenotype is atypical for ApoE/ mice but can be ob-
served in ApoE/ mice after they were fed a Western
diet for 10 months (Nakashima et al., 1994; Reddick
et al., 1994), in mice that lack both the low-density lipopro-
tein (LDL) receptor and ApoE fed on a high cholesterol diet
for 7 months (Caligiuri et al., 1999), scavenger receptor B1
(SR-BI)-deficient mice bred on an ApoE/ backgroundetabolism 6, 446–457, December 2007 ª2007 Elsevier Inc. 447
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Coronary Atherosclerosis in Absence of Akt1Figure 2. The Absence of Akt1 Increases Lesion Expansion in the Innominate Artery in ApoE/ Mice
Representative histological analysis of cross-sections from the brachiocephalic arteries stained with hematoxylin and eosin, trichrome, oil red O,
CD68 (a macrophage marker), and a-smooth muscle cell actin. Quantification of atheroma area is shown (right panel). All of the data represent
the mean ± SEM; n = 5 mice (males) in each group.(Braun et al., 2002), or ApoE/ bred to mice transgeni-
cally expressing urokinase in macrophages (Cozen et al.,
2004). Next, we confirmed occlusive coronary artery dis-
ease by ex vivo angiography (Figure 1H). Thus, the genetic
loss of Akt1 increases aortic and coronary atherogenesis.
In addition to these coronary lesions observed in absence
of Akt1, we also found a marked atherogenesis, and al-
most occlusive lesions, in the innominate artery of doubly
mutant mice (Figure 2). As a possible consequence of this
accelerated atherosclerosis, we found significant mortal-
ity in ApoE/Akt1/ mice (5 of 22 animals died prior to
the end of the feeding period, whereas 0 of 42 ApoE/
died).
Reduced Body Weight and No Change in Lipids
in the Absence of Akt1
Next, we examined multiple metabolic parameters of the
mice. Body weights were significantly lower in the
ApoE/Akt1/ versusApoE/mice (Figure 3A). Plasma
triglycerides, cholesterol levels, and lipoprotein profiles
were similar in both groups before and after they were
fed a high cholesterol diet (Figures 3B–3D), indicating
that the increase in lesion formation occurred indepen-
dently of the plasma lipid profiles in the ApoE/Akt1/
double-mutant mice.
Deletion of Akt1 Decreases Endothelial Cell
Proliferation and Viability
To determine the potential mechanisms of enhanced
atherosclerosis in the double-mutant mice, we initially an-
alyzed Akt1 protein expression in cell types traditionally448 Cell Metabolism 6, 446–457, December 2007 ª2007 Elsevassociated with the development of atherosclerosis:
endothelial cells (ECs), vascular smooth muscle cells
(VSMCs), and monocytes. As seen in Figure 4A, Akt1 is
the major isoform expressed in all of the cell types exam-
ined. A classic hypothesis of atherogenesis has sug-
gested that the ‘‘dysfunction’’ of ECs is an important early
event for the development of atherosclerosis (Littlewood
and Bennett, 2003; Tricot et al., 2000) and sites where pla-
ques develop might be associated with impaired EC func-
tion and apoptosis. To investigate whether Akt1 is impor-
tant for regulating EC proliferation and viability, we
analyzed EC proliferation at different time points and hy-
podiploid cells by flow cytometry. As shown in Figure 4B,
ECs isolated from Akt1/ mice did not grow as well as
cells isolated from WT mice. Furthermore, the reintroduc-
tion of Akt1 (by retrovirus) into Akt1/ ECs rescued the
defective proliferation phenotype. Similar results were ob-
tained when we analyzed the cell viability after serum star-
vation (Figure 4C). ECs lacking Akt1 were more apoptotic
after treatment with ceramide (as an apoptogen) using
double staining (propidium iodide and annexin V) analysis
by flow cytometry (Figure 4D) and cleaved caspase-3 ex-
pression analysis by western blotting (Figure 4E). In iso-
lated aortic rings from Akt1/ mice, ceramide induced
greater EC apoptosis (detected by TUNEL staining) as
examined by en face imaging of ECs (with PECAM-1 as
amarker; Figure 4F, quantified in the right panel). Because
EC apoptosis has been suggested as an initial step in ath-
erogenesis, we studied EC apoptosis in the early stages of
the lesion development in mice fed with a high cholesterol
diet for only 1 month. As seen in Figure 4G, there wasier Inc.
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Coronary Atherosclerosis in Absence of Akt1Figure 3. Reduced Body Weight in Absence of Akt1 and Similar Values of Cholesterol, Triglycerides, and Lipoprotein Profiles
(A) Body weight of Akt1+/+ApoE/ (n = 10) and Akt1/ApoE/ (n = 8) mice before and after 12 weeks on a high cholesterol diet. * indicates p < 0.05
compared with Akt1+/+ApoE/.
(B) Fasting cholesterol levels of ApoE/ and Akt1/ApoE/ mice before and after 12 weeks on a high cholesterol diet.
(C) Fasting triglycerides levels from both groups of mice before and after 12 weeks on a high cholesterol diet.
(D and E) Lipoprotein profiles from ApoE/ and double-mutant mice before and after diet.a marked increase in apoptotic ECs in aortic lesions from
ApoE/Akt1/ mice compared to littermate control
mice.
Akt1 and Macrophage Function
Foam cell formation is a crucial step in atherogenesis
(Glass andWitztum, 2001; Li and Glass, 2002). Circulating
monocytes adhere to the activated endothelial cells and
transmigrate into the intima to become tissue macro-
phages. Upon exposure to modified lipoproteins such as
oxidized LDL, these macrophages differentiate into foam
cells. To test whether Akt1 is important in monocyte adhe-
sion, spreading, and migration, we examined these pro-
cesses in monocytes isolated from bone marrow. The ad-
hesion, spreading, and chemokine-induced (MCP-1 and
M-CSF) migration of monocytes was equivalent in cells
isolated both groups of mice (Figure S2). Next, we inves-
tigated the binding and uptake of fluorescently labeled
acetylated LDL (DiI-acLDL). Flow cytometry analysis re-
vealed no differences in the binding of lipoproteins
(Figure 5A) and a slight decrease in the uptake of DiI-
acLDL (Figure 5B). To examine cholesterol ester accumu-
lation as an index of foam cell formation in vitro, we iso-
lated peritoneal macrophages from ApoE/Akt1/ and
ApoE/mice and exposed them to oxidized LDL (oxLDL)Cell Min vitro. As shown in Figure 5C, lipid accumulation in both
groups was not significantly altered.
Akt1/ Macrophages Are More Susceptible to
Apoptosis
The death of foam cells by necrosis or apoptosis, particu-
larly in the face of defective phagocytic clearance of the
dead foam cells, is thought to give rise to large regions
within plaques composed of extra cellular lipid and ne-
crotic debris (Li and Glass, 2002; Tabas, 2002). Interest-
ingly, insulin-receptor-deficient macrophages promoted
atherogenesis, which correlated with lower levels of Akt
phosphorylation (Han et al., 2006). To evaluate the role
of Akt1 in macrophage survival, we incubated peritoneal
macrophages in presence of oxLDL for 24 hr, and the hy-
podiploid cells (necrotic and apoptotic cells) were ana-
lyzed by FACS. As seen in Figure 5D, ApoE/Akt1/
cells were more susceptible to oxLDL-induced apoptosis
than were control cells. In another set of experiments, to
induce free cholesterol loading, we incibated macro-
phages with acetylated LDL (acLDL) in the presence of
an ACAT inhibitor (58035) or oxLDL for 24 hr.Akt1/mac-
rophages showed an increase in apoptosis under both
conditions (Figure 5E), indicating the important role of Akt1
in macrophage survival pathways. Increased numbersetabolism 6, 446–457, December 2007 ª2007 Elsevier Inc. 449
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Coronary Atherosclerosis in Absence of Akt1Figure 4. Absence of Akt1, the Predominant Isoform in ECs, VSMCs, and Monocytes, Reduces Endothelial Cell Proliferation and
Viability In Vitro and In Vivo
(A) Western blot analysis and densitometry of total Akt protein expression levels in lung ECs, aortic VSMCs, and bone-marrow derived monocytes.
(B and C) EC proliferation (B) measured as viable cell number and apoptotic cells (C) determined by their hypochromic, subdiploid staining profiles
(SubG1 population) after incubation of thewild-type andAkt1/ ECs in absence of serum at different time points. The data represent themean ± SEM
of triplicate samples repeated in three separate experiments. * indicates p < 0.05 compared with wild-type cells.
(D) Phase-contrast micrographs of cultures treated or not for 24 hr with ceramide (30 mM) and dot-plot diagrams of FITC-conjugated annexin V and PI.
Results are representative of two separate experiments that gave similar results.
(E) Western blot analyses of cleaved caspase-3, Akt, and phopho-Akt473 from wild-type and Akt1/ ECs treated with ceramide (30 mM) for 12 and
24 hr. The western blots are representative of two separate experiments that gave similar results.
(F) Whole-mount en face immunostaining of WT and Akt1/ aortas treated with ceramide (30 mM) for 24 hr. Apoptotic cells were detected by TUNEL
staining and ECs by PECAM-1 staining. Representative fluorescent images (203 magnification) are shown, and quantitative data are shown to the
right. The data are expressed as the percentage of TUNEL-positive cells per field (four fields per three mice each group). The scale bars represent
25 mm.
(G) Apoptotic cells in the lesion area from ApoE/ and ApoE/Akt1/ after 4 weeks of a high cholesterol diet were detected by TUNEL staining.
Representative fluorescence images are shown, and quantitative data are shown to the right. The scale bars represent 25 mm.of TUNEL-positive, CD68-positive macrophages were
present in lesions from ApoE/Akt1/ compared with
ApoE/ mice (Figure 5F, quantified in the right panel).
ApoE/ Bone Marrow Cells Do Not Rescue
Double-Mutant Atherosclerosis
To test whether an Akt1-dependent survival mechanism in
macrophages accounts for the increase of atherosclerosis
in the double-mutant mice, we performed bone marrow
transplantation experiments. Bone marrow from ApoE/
or ApoE/Akt1/ was transplanted into 6-week-old,
lethally irradiated ApoE/Akt1/ or ApoE/ mice, re-450 Cell Metabolism 6, 446–457, December 2007 ª2007 Elseviespectively. After 4 weeks of reconstitution, mice were
fed with a high cholesterol diet for 12 weeks. ApoE/
Akt1/ bone marrow cells transplanted into ApoE/
mice were not sufficient to worsen lesion progression
compared with ApoE/ bone marrow transplanted into
ApoE/Akt1/ hosts (see Figure 5G en face and Fig-
ure 5H for cross sections), demonstrating that the loss of
Akt1 in bone-marrow-derived macrophages could not
fully account for the enhanced aortic atherosclerosis in
ApoE/Akt1/ mice. These data suggest that vascular
dysfunction in host mice lacking Akt1 is likely a major
cause of lesion progression in ApoE/Akt1/ mice.r Inc.
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Coronary Atherosclerosis in Absence of Akt1Figure 5. Akt1/Macrophages Display Similar Binding to Lipoproteins and Foam Cell Formation and Show Increased Suscepti-
bility to Apoptosis by Cholesterol Overload
(A and B) Specific binding (A) and uptake (B) of DiI-labeled acLDL in peritoneal macrophages isolated from ApoE/ and ApoE/Akt1/mice. The
data are the mean ± SEM of triplicate samples repeated in two separate experiments.
(C) Foam cells from ApoE/ and ApoE/Akt1/mice treated with oxLDL for 24 hr and quantitative analysis of three independent experiments. The
scale bars represent 50 mm.
(D) Apoptotic cells determined by their hypochromic, subdiploid staining profiles (SubG1 population) after the incubation of ApoE/ and ApoE/
Akt1/ peritoneal macrophages with 100 mg/ml oxLDL for 24 hr. The data are the mean ± SEM of triplicate samples repeated from three different
groups of mice. * indicates p < 0.05 compared with ApoE/.
(E) Quantitative determination of apoptotic macrophages stained positive for annexin V. Thioglicollate-elicited peritoneal macrophages from either
ApoE/ (upper panels) and ApoE/Akt1/ (lower panels) mice were incubated with or without acLDL (100 mg/ml) and 58035, (10 mg/ml) an
ACAT inhibitor, or oxLDL (100 mg/ml) for 36 hr. All results represent the mean ± SEM of triplicate samples from three different sets of mice. The scale
bars represent 100 mm.
(F) Apoptotic cells and macrophages in lesions from ApoE/ and ApoE/Akt1/ mice after 12 weeks of a high cholesterol diet were detected by
TUNEL and CD68 staining, respectively. The data are expressed as the number of TUNEL-positive cells per mm2 cellular lesion area. The scale bars
represent 100 mm.
(GandH)Transplantationof bonemarrowcells fromApoE/orApoE/Akt1/mice intoApoE/Akt1/orApoE/mice, respectively, followedby
lesion analysis in aorta (G) and cross-sections of aortic sinus (H). The data are themean ± SEM from 5mice (males) in each group.) indicates p < 0.05.Vessel Wall Inflammation Increased and
Phosphorylated eNOS Decreased in Absence
of Akt1
Finally, to appreciate the multiple mechanisms of athero-
genesis in intact vessels, we analyzed the quantitative ex-
pression patterns of markers of inflammation in the vessel
wall of ApoE/Akt1/ and ApoE/mice after 3 months
on a high cholesterol diet by quantitative polymerase
chain reaction (qPCR) array technology. As seen in Fig-
ure 6A, the expression levels of several inflammatoryCell Memolecules were significantly upregulated in the double-
mutant mice compared to ApoE/ alone, such us inter-
leukin-6 (IL-6), interleukin-13 receptor a 2 (IL-13ra2), and
tumor necrosis factor (Tnf). Vascular cell adhesion mole-
cule 1 (VCAM-1), which is expressed after the activation
of endothelial cells and mediates the adhesion of leuko-
cytes (Glass and Witztum, 2001), was also increased in
ApoE /Akt1/ aorta. Placental growth factor (Pgf)
was increased, whereas the angiogenesis inhibitor throm-
bospondin-1 (Thbs1) was decreased in the doubly mutanttabolism 6, 446–457, December 2007 ª2007 Elsevier Inc. 451
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Coronary Atherosclerosis in Absence of Akt1mice. To determine whether the difference in proinflam-
matory gene expression was due to differences in intrinsic
gene expression, cellularity, or plaque composition in
doubly mutant mice, we analyzed the expression of these
genes in aortae from both groups of 2-month-old mice fed
a normal chow diet. As seen in Figure S3, no basal differ-
ences in gene expression were observed in either group of
mice.
We confirmed the increase of VCAM-1 expression in
whole aorta by western blotting (Figure 6B, quantified in
Figure 6C). In addition, the levels of CD36, a member of
the class B scavenger receptor family proteins involved
in lipoprotein uptake (Calvo et al., 1998), and F4/80,
a membrane protein both expressed in monocytes and
Figure 6. Loss of Akt1 Alters the Expression Profile of Athero-
sclerosis-Related Genes and Proteins
(A) Expression profile of atherosclerosis-related genes assessed with
PCR Array technology. Three independent arrays were carried out
for each condition with iCycler (BioRad). The n-fold change for each
gene from mice after diet to before diet was calculated. The data
represent themean ± SEMof triplicate simples. White bars correspond
to ApoE/ mice and black bars to double-mutant mice.
(B and C) Western blot analyses (B) and band densitometry (C) of
CD36, F4/80, eNOS, peNOS-1176, eNOS, Akt, pAkt473, pAkt308,
and Akt1 from Akt1+/+ApoE/ and Akt1/ApoE/ mice feed with
a high cholesterol diet for 12 weeks. Results from three representative
mice are shown for each genotype. The data represent the mean ±
SEM of triplicate samples. * indicates p < 0.05 compared with Akt1+/+
ApoE/.452 Cell Metabolism 6, 446–457, December 2007 ª2007 Elsevimacrophages, were highly expressed in both strains, but
only F4/80 levels were statistically increased ApoE/
Akt1/ aortic lysates (Figures 6B and 6C). The increase
in inflammation and macrophages was associated with
a marked reduction of eNOS phosphorylation on S1176
(but not total eNOS levels), consistent with the existence
of less phosphorylation in both residues of Akt and less to-
tal expression of Akt. The decrease in eNOS phosphoryla-
tion on S1176 was also seen on an additional Akt site
(S617) with ECs isolated from Akt1/ mice; the reintro-
duction of Akt1 in Akt1/ ECs rescued the defective
phosphorylation phenotype (Figure S4).
Next, we analyzed the cellular localization of VCAM-1 in
atherosclerotic lesions. As seen in Figure 7A, immunore-
active VCAM-1 is found in PECAM-1-positive ECs but is
also highly expressed in CD68-positive foam cells in the
atherosclerotic plaques. To test whether the increase in
VCAM-1 expression correlated with more infiltration of
macrophages into the lesion, we quantified VCAM-1 in
CD68-positive cells. As shown in Figure 7B, the macro-
phage infiltration (depicted by CD68-positive cells) was
significantly higher in absence of Akt1. Moreover, the rel-
ative fluorescent intensity of VCAM-1 versus CD68 levels
did not change, indicating that the enhanced levels of
VCAM-1 are due to increased macrophage infiltration in
mice lacking Akt1 (Figure 7C). To directly examine
whether the loss Akt1 influences VCAM-1 expression in
ECs, ICAM-1, and VCAM-1, we quantified surface levels
by flow cytometry in ECs isolated from WT and Akt1/
mice after stimulation with tumor necrosis factor
a (TNFa). As seen in Figure 7D, the absence of Akt1 did
not affect significantly the VCAM-1 and ICAM-1 expres-
sion in endothelial cells. Collectively, these data demon-
strate that enhanced proinflammatory gene expression
is secondary to macrophage infiltration in mice lacking
Akt1 and that the changing plaque composition triggered
by EC dysfunction leads to an increased inflammatory pla-
que phenotype and larger lesions.
DISCUSSION
The major finding of this study is that a global absence of
Akt1 in vivo enhances atherosclerotic lesion burden and
promotes coronary atherosclerosis in a mouse model of
atherosclerosis. Mechanistically, this phenotype is due to
an increase in proatherogenic pathways, such as en-
hanced apoptosis and less eNOS phosphorylation in
ECs, and increased apoptosis inmacrophages. Traditional
hypotheses of atherogenesis have suggested that the
injury or dysfunction of vascular ECs is critical for the de-
velopment of atherosclerosis (Littlewood and Bennett,
2003; Ross, 1990). The anatomical sites where atheromas
develop are associated with perturbed hemodynamics
and increased EC turnover rate, suggesting a mechanical
link with enhanced susceptibility to atherosclerosis, per-
haps due to a decrease in NO bioavailability and an in-
crease in EC apoptosis (Dimmeler et al., 1998). It has
been reported that the regeneratedECsat sites of vascular
damage do not function correctly (Fournet-Bourguignoner Inc.
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Coronary Atherosclerosis in Absence of Akt1Figure 7. Increased Macrophage Infiltration and VCAM-1 Expression in the Absence of Akt1
(A and B) Representative examples of cross sections from the aortic sinus labeled for VCAM-1, CD68, and PECAM-1. The scale bars represent
100 mm.
(C) CD68-positive macrophages in lesions from ApoE/ and ApoE/Akt1/mice after 12 weeks of a high cholesterol diet were detected by CD68
staining. The data are quantified as CD68-positive area versus total lesion area (upper right panel) and the relative fluorescence intensity of VCAM-1
(red channel) in the CD68-positive area (green channel, bottom right panel). The data represent the mean ± SEM; n = 5 mice (male) in each group.
(D) VCAM-1 (top) and ICAM-1 (bottom) expression analysis by flow cytometry in endothelial cells isolated fromWT or Akt1 KOmice that were treated
with TNFa for 16 hr. These data are representative of three separate experiments that yielded similar results.et al., 2000); these dysfunctional cells will therefore be
unable to provide sufficient atheroprotection because
they are deficient in NO bioactivity and other indices of
endothelial dysfunction. In addition, the enhancedsuscep-
tibility of the endothelium to local oxidative stress fromLDL
might change the apoptotic threshold in the absence of
Akt1 and accelerate atherogenesis, as observed in our
model.
The relationship between macrophage apoptosis and
atherogenesis is also complex (Tabas, 2005). ResultsCell Metfrom bone marrow transplantation studies with mice defi-
cient in AIM (apoptosis inhibitor expressed by macro-
phages) or BAX, a proapoptotic protein, suggest that en-
hanced macrophage apoptosis in developing foam cells
appears to limit lesion inflammation and progression
(Arai et al., 2005; Liu et al., 2005). However, apoptotic
macrophages are more abundant in advanced versus
early atherosclerotic lesions, suggesting reduced or de-
fective phagocytic clearance in advanced lesions
(Tabas, 2002; Tabas, 2005). This would result inabolism 6, 446–457, December 2007 ª2007 Elsevier Inc. 453
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Coronary Atherosclerosis in Absence of Akt1postapoptotic macrophage necrosis and a heightened
state of inflammation in the vessel wall (Ball et al., 1995;
Libby, 2002). In accordance with this, we found increased
macrophage infiltration and increased proinflammatory
gene expression (TNFa and IL-6) in vessels lacking Akt1.
TNFa and IL-6 are amply expressed by foam cell macro-
phages (Li et al., 2005), and increased VCAM-1 and
ICAM-1 expression on endothelial cells supports the fur-
ther recruitment of monocytes into the atherosclerotic
plaque (Tedgui and Mallat, 2006). Although VCAM-1 is in-
ducibly expressed on ECs, there is also marked expres-
sion of VCAM-1 on macrophages (Trogan et al., 2002),
although its ligands and roles in atherogenesis are not
known.
In contradistinction to the antiatherosclerotic role of en-
dogenousAkt inApoE/Akt1/mice, the loss of Akt1 re-
duced LDL uptake by macrophages. This phenotype
would favor atheroprotective mechanisms in the absence
of Akt1 but clearly does not account for the role of Akt1
in vivo. Our data suggesting that Akt is atheroprotective
via a vascular specific mechanism are supported by re-
cent experiments showing that Akt1 is critical for endoge-
nous NO production (Ackah et al., 2005) and vascular cell
survival and that the transgenic expression of activated
Akt in the endothelium reduces vascular lesion formation
in vivo (Mukai et al., 2006).
Murine models of atherosclerosis, such as apoE or the
LDL receptor knockout mice, usually do not exhibit many
of the cardinal features of human coronary heart disease,
such as spontaneous myocardial infarction, athero-
thrombosis, and premature death. Importantly, we de-
scribe here that the absence of Akt1 leads to extensive
coronary atherosclerosis and increased mortality, un-
usual phenotypes previously observed in mice lacking
at least two components of the cholesterol metabolic
pathway (Braun et al., 2002; Caligiuri et al., 1999). Inter-
estingly, peripheral coronary atherosclerosis was also
observed in eNOS-deficient mice bred to an atheroscle-
rotic background (Kuhlencordt et al., 2001), which corre-
lates with the reduce eNOS phosphorylation and activity
that we observed in ourmodel. Further studies are neces-
sary to delineate the role of Akt1 in modifying plaque
composition and to dissect the absolute importance of
Akt1 in macrophages versus Akt1 in ECs. However,
bone marrow transplantation experiments favor a critical
role of host Akt1 relative to macrophage Akt1 in this
model. Collectively, these results suggest that the loss
of Akt1 decreases EC NO production, promoting EC ac-
tivation, which changes the apoptotic balance of vascular
cells and macrophages, thereby contributing to the pro-
gression of atherosclerosis. Thus, the specific activation
of Akt1 could provide a therapeutic approach to de-
crease atheroma formation and promote plaque stabili-
zation while antagonizing Akt, an approach that should
reduce tumor progression, could facilitate the progres-
sion of atherosclerosis. The increased atherogenesis in
mice lacking Akt1 is mechanistically linked to endothelial
cell dysfunction and enhanced macrophage-dependent
vascular inflammation.454 Cell Metabolism 6, 446–457, December 2007 ª2007 ElsevieEXPERIMENTAL PROCEDURES
Animal Procedures
Akt1/ mice were generated as previously described (Cho et al.,
2001b). Akt1/ mice that have been backcrossed eight generations
onto a C57BL/6 background were crossed with ApoE-deficient mice,
also on the C57BL/6 background, so that mice heterozygous at both
loci could be generated. These ApoE+/Akt1+/ mice were crossed a
second time with ApoE/ mice. The ApoE/Akt1/+ progeny from
this round of breeding were then intercrossed, producing ApoE/
Akt1/ and ApoE/Akt1+/+ littermates that were used as controls for
all studies. Accelerated atherosclerosis was induced by feeding the
mice for 14weekswith a high cholesterol diet containing 1.25%choles-
terol (ResearchDiets, D12108). All of the experimentswere approvedby
the Institutional Animal Care Use Committee of Yale University.
Lipids Analysis and Lipoprotein Profile Measurement
Mice were fasted for 12–14 hr before blood samples were collected by
retro-orbital venous plexus puncture. Plasmawas separated by centri-
fugation and stored at 80C. Total plasma cholesterol and triglycer-
ides were enzymatically measured with the Amplex red cholesterol as-
say kit (Molecular Probes) and serum triglyceride determination kit
(Sigma), respectively, according to the manufacture’s instructions.
The lipid distribution in plasma lipoprotein fractions were assessed
by fast-performance liquid chromatography (FPLC) gel filtration with
2 Superose 6 HR 10/30 columns (Pharmacia).
Bone Marrow Transplantation
Eight-week-old male or female ApoE/ or Akt1/+ApoE/ were le-
thally irradiatedwith 1000 rads (10Gy) from a cesium source 4 hr before
transplantation. Bone marrow was collected from femurs of donor
ApoE/ or ApoE/Akt1/ mice by flushing with sterile medium
(RPMI 1640, 2% fetal bovine serum [FBS], 5U/ml heparin, 50U/ml pen-
icillin, and 50 mg/ml streptomycin). Each recipient mouse was injected
with 2 3 106 bone marrow cells through the jugular vein. Four weeks
after bone marrow (BM) transplantation, peripheral blood was col-
lected by retro-orbital venous plexus puncture for PCR analysis of
bone marrow reconstitution. For atherosclerosis study, the mice
were fed with high cholesterol diet for 10 weeks beginning 4 weeks
after BM transplantation and, on the basis of PCR genotyping, were
fully chimeric.
Atherosclerotic Lesion Analysis
After 12 weeks of being fed a Western-type diet, mice were anesthe-
tized and euthanized. Mouse hearts were perfused with 10 ml of phos-
phate-buffered saline (PBS) (Invitrogen) and then 10 ml of 4% parafor-
maldehyde (PFA). After incubation in 4% PFA overnight, the adventitia
was thoroughly cleaned under a dissecting microscope, and the aorta
was cut open longitudinally and pinned on to a silicone plate. So that
the lesion area could be calculated, aortas were stained with oil red
O (Sigma) before the analysis. Oil red stock solution (35 ml; 0.2%
weight/volume in methanol) was mixed with 10ml of 1 MNaOH and fil-
tered. Aortas were briefly rinsed with 78% methanol, incubated in oil
red O solution for 50 min, and then destained in 78% methanol for
5 min and mounted on microscopic slides with aqueous mounting me-
dium (Stephens Scientific). Plaques were analyzed under the Nikon
SMZ 1000 microscope connected to a Kodak DC290 digital camera.
The images were analyzed with Adobe Photoshop 6.0 (Adobe), and
the lesions were quantified with the IMAGE J (National Institutes of
Health [NIH]) program. For other images, 10-mm-thick cryosections
of the proximal aorta were serially sectioned and stained with hema-
toxylin and eosin for quantifications of the lesion areas with the IMAGE
J program. The aortic lesion size of each animal was obtained by the
averaging of lesion areas in six sections from the same mouse.
Angiography
After 12 weeks on high cholesterol diet, mice were anesthetized and
heparinzed. The hearts ascending aorta was perfused with PBSr Inc.
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ter) for 3 min at physiological pressure through descending aorta,
and blood was drained from the right atrium. The vasculature were
fixed with 2% paraformaldehyde (in PBS) for 5 min, flushed with PBS
for 2 min, and infused with contrast agent (bismuth oxychloride in sa-
line and 10% gelatin in PBS 1:1). Mice were then immersed in ice so
that the contrast agent could be solidified. Microangiography was
taken with Faxitron X-ray machine (Hewlett-Packard) at 25 kV for 15 s.
MLEC Isolation
Mouse lung endothelial cells (MLECs) were isolated from 3-week-old
Akt1/ andWTmice. In brief, mice were euthanized with an overdose
of ketamine and xylazine, and the lungs were excised, minced, and di-
gested with 0.1% collagenase in RPMI medium. The digest was ho-
mogenized by passing multiple times through a 14 gauge needle. It
was then filtered through a 150 mm tissue sieve, and the cell suspen-
sion was plated on 0.1 gelatin-coated dishes. After 2 to 3 days, cells
were immortalized by two rounds of infection with retrovirus encoding
the middle T antigen. Cells were allowed to recover for 24 hr, and then
ECs were isolated by immunoselection with PECAM-1- and ICAM-2-
conjugatedmagnetic beads.When cells reached confluency, a second
round of immunoselection was performed. Cells were propagated in
EGM-2 media supplemented with EGM-2 microvascular (MV) Single-
Quots (Cambrex). For Akt1/ reconstitution, cells were infected twice
with a retrovirus encoding either hemagglutinin (HA)-tagged murine
Akt1 or green fluorescent protein (GFP).
Cell Migration Assay
Cell migraton assays were performed with a modified Boyden cham-
ber with Costar Transwell inserts (Corning). The inserts were coated
with a solution of 0.1% gelatin. Subconfluent monocytes were serum
starved overnight. Solutions of MCP-1 (100 ng/ml), M-CSF (100 ng/
ml), and 10% FBS were prepared in Dulbecco’s modified Eagle’s me-
dium (DMEM) and added to the bottom chambers. Monocytes (7.5 3
104 cells) were added to the upper chambers. After 6 hr incubation at
37C, cells on both sides of the membrane were fixed and stained with
the Diff-Quik staining kit (Baxter Health). Cells on the upper side of the
membrane were removed with a cotton swab. The average number of
cells per field on the lower side of the membrane from 4 high-power
(3400) fields was counted.
Cell Proliferation Assay
Cell number and viability was determined by Tripan blue dye exclusion
with a hemocytometer.
Foam Cell Formation
Thioglycolate-elicited peritoneal macrophages were plated on 12-well
plates in RPMI 1640 supplemented with 10% FBS, 100 units/ml peni-
cillin, and 100 mg/ml streptomycin. After 2 hr, nonadherent cells were
washed out, and macrophages were incubated in fresh medium for
24 hr. Then, oxLDL (100 mg/ml) (Intracel) was added to the medium.
After about 24 hr, cells were stained for 60 min with oil red O.
Binding and Uptake of acLDL
Thioglycolate-elicited peritoneal macrophages were plated on 6 cm
dishes in RPMI 1640 supplemented with 10% FBS, 100 units/ml pen-
icillin, and 100 mg/ml streptomycin. After 2 hr, nonadherent cells were
washed out, and macrophages were incubated in RPMI 1640 medium
supplemented with 10% lipoprotein-deficient media (LPDS) for 24 hr.
For binding studies, adherent cells were incubated with 10 mg/ml
DiI-acLDL for 2 hr at 4C. So that the uptake of DiI-acLDL could be
analyzed, cells were incubated for 2 hr at 37C. In order to exclude
nonspecific binding and uptake, we supplemented the medium with
an excess of unlabeled acLDL (200 mg/ml). Finally, the samples were
washed, resuspended in 1 ml of PBS, and analyzed by flow cytometry
(FACSort, Becton Dickinson). The results are expressed in terms of
specific median intensity of fluorescence (M.I.F.) after M.I.F. of cells
incubated in excess of unlabelled acLDL was subtracted.Cell MWestern Blot Analysis
Tissues were snap frozen in liquid nitrogen, pulverized, and resus-
pended in lysis buffer (50mMTris-HCl [pH 7.4], 0.1 mM ethylenediami-
netetraacetic acid (EDTA), 0.1 mM ethylene glycol tetraacetic acid
(EGTA), 1%NP-40, 0,1% sodium deoxycholate, 0,1% sodium dodecyl
sulfate (SDS), 100 mM NaCl, 10 mM NaF, 1 mM sodium pyrophos-
phate, 1 mM sodium orthovanadate, 1 mM Pefabloc SC, and 2 mg/
ml protease inhibitor cocktail [Roche Diagnostics]). Cells were lysed
on ice with lysis buffer as noted above. Protein concentrations were
determined with the DC Protein assay kit (Bio-Rad Laboratories). Ly-
sates containing 80 mg (tissue) or 30 mg (cells) of protein were analyzed
by SDS-polyacrylamide gel electrophoresis (PAGE) and immunoblot-
ting. Primary antibodies used include the following: Akt1 m-Ab (Up-
state), Akt p-Ab, p-Akt473 p-Ab, p-Akt308 m-Ab, cleaved caspase3
p-Ab, caspase3 (Cell signaling), eNOS m-Ab, heat shock protein
(Hsp90) m-Ab (BD Transduction Laboratories; BD Biosciences-Phar-
Mingen), CD36 p-Ab, VCAM-1 p-Ab (Santa Cruz), and F4/80 (Serotec).
Secondary antibodies were fluorescence-labeled antibodies (LI-COR
Biotechnology). Bands were visualized with the Odyssey Infrared
Imaging System (LI-COR Biotechnology).
Flow Cytometry Analysis
Apoptotic cells were determined by their hypochromic, subdiploid
staining profiles (SubG1 population). Serum-starved ECs or peritoneal
macrophages cultured in presence of 100 mg/ml oxLDL were stained
with propidium iodide (PI) and analyzed by flow cytometry (FACSort,
Becton Dickinson). For staining, one million cells were harvested,
washed in PBS, and then fixed with 70% ethanol. Fixed cells were
treated with DNase-free RNase (Roche) for 30 min at 37C, washed
in PBS, centrifuged, and incubated in PBS containing PI (25 mg/ml;
Sigma). Forward light scatter characteristics were used so that cell de-
bris could be excluded from the analysis. For the estimation of early
apoptosis cells, Alexa fluorescein isothiocyanate (FITC)-conjugated
annexin V (Molecular Probes) was used together with PI dead cell
counterstain according to the manufacturer’s recommendations.
Macrophage Apoptosis Assays
Peritoneal macrophages from WT and Akt1/ mice fed regular chow
diet were harvested with PBS 3 days after the intraperitoneal injection
of thioglycolate. The macrophages were plated on 12-well plates in
RPMI 1640 supplemented with 10% FBS, 100 units/ml penicillin, and
100 mg/ml streptomycin. After 2 hr, nonadherent cells were washed
out, and macrophages were incubated in fresh medium for 24 hr.
Then, cells were incubated with 100 mg/ml acLDL (Intracel) and 10
mg/ml 58035, an ACAT inhibitor (Sigma), or with 100 mg/ml oxLDL (In-
tracel) for about 24 hr. Apoptosis assays were performed by the stain-
ing of macrophages with Alexa 488-labeled annexin V with the Vybrant
Apoptosis Assay Kit (Molecular Probes) or the analysis of the subdi-
ploid staining profiles (SubG1 population) as described above.
Immunohistochemistry
Snap-frozen fixed aortic rings embedded in optimal cutting tempera-
ture (OCT) were sectioned, fixed in acetone, and processed for anti-
body staining according to standard protocols. The following anti-
bodies were used: anti PECAM-1 (BD Biosciences) and CD68
(Serotec). Positive cells and total cells were quantified of the aortic
arch (five different sections) from four different mice of each genotyp-
ing with IMAGE J software. Whole-mount immunostaining was per-
formed as previously described (Murata et al., 2002). After the fixation,
arteries were probed with anti-PECAM antibody (1:200) for 12 hr at
4C. For the detection of apoptosis, FITC-labeled dUTP nick end-
labeling (TUNEL) method was applied to the sections with an In Situ
Apoptosis Detection Kit-POD according to the instruction (Roche
Diagnostics).
Gene Expression Analysis by PCR Array
RT2 Profiler PCR Array from SuperArray Bioscience Corporation was
used for the examination of the expression pattern of genes involvedetabolism 6, 446–457, December 2007 ª2007 Elsevier Inc. 455
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modulation of atherosclerosis, angiogenesis, and inflammation, as
well as five housekeeping (HK) genes used for the normalization of
the PCR Array data. By using different arrays, we compared the aortic
gene expression of mice before and after 3 months of diet. For these
experiments, a combined TRizol (Qiagen) protocol was used for the
extraction of RNA. In brief, aortas were isolated, frozen, crushed,
and resuspended in 1 ml TRIzol. The RNA-containing phase was
recovered after spinning for 10 min at 10,0003 g, mixed with an equal
volume of 70% ethanol, and applied on a QIAGEN RNeasy column.
The remaining steps were carried out according to QIAGEN’s proto-
cols. Complementary DNA (cDNA) was prepared as above from 2 mg
of total RNA. Then the Real-Time PCR Array was performed as indi-
cated in the user manual with the specific RT2 Real-Time SYBR
Green/Fluorescein (SuperArray Bioscience Corporation). Three inde-
pendent arrays were carried out for each condition with iCycler (Bio-
Rad). The n-fold change for each gene from mice after diet to before
diet was calculated as 2(DDCt
), where DDCt = DCt after diet  DCt be-
fore diet and where DCt = Ct gene of interest – Ct average of HK genes for each
treatment.
Statistical Analysis
Data are presented as mean ± the standard error of the mean (SEM)
(n is noted in the fig legends), and the statistical significance of differ-
ences was evaluated with the Student’s t test. Significance was
accepted at the level of p < 0.05.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures
and four figures and can be found with this article online at http://
www.cellmetabolism.org/cgi/content/full/6/6/446/DC1/.
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